Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Significance of lymph node involvement in local recurrence of colorectal cancer.
Dumont F, Muñoz MA, De Franco V, Wernert R, Verriele V, Heyman MF, Kerdraon O, Capitain O, Guerin-Meyer V, Raimbourg J, Senellart H, Hiret S, Raoul JL, Thibaudeau E. Dumont F, et al. Among authors: kerdraon o. J Surg Oncol. 2019 Sep;120(4):722-728. doi: 10.1002/jso.25631. Epub 2019 Jul 22. J Surg Oncol. 2019. PMID: 31332806
Intra-abdominal recurrence from colorectal carcinoma: Differences and similarities between local and peritoneal recurrence.
Dumont F, Joseph S, Lorimier G, De Franco V, Wernert R, Verriele V, Kerdraon O, Campion L, Capitain O, Guerin-Meyer V, Raimbourg J, Senellart H, Hiret S, Raoul JL, Thibaudeau E. Dumont F, et al. Among authors: kerdraon o. Surg Oncol. 2020 Mar;32:23-29. doi: 10.1016/j.suronc.2019.10.018. Epub 2019 Nov 4. Surg Oncol. 2020. PMID: 31707314
The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression.
Eugène J, Jouand N, Ducoin K, Dansette D, Oger R, Deleine C, Leveque E, Meurette G, Podevin J, Matysiak T, Bennouna J, Bezieau S, Volteau C, Thomas WEA, Chetritt J, Kerdraon O, Fourquier P, Thibaudeau E, Dumont F, Mosnier JF, Toquet C, Jarry A, Gervois N, Bossard C. Eugène J, et al. Among authors: kerdraon o. Mod Pathol. 2020 Mar;33(3):468-482. doi: 10.1038/s41379-019-0322-9. Epub 2019 Aug 13. Mod Pathol. 2020. PMID: 31409873 Free article.
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications.
Jézéquel P, Kerdraon O, Hondermarck H, Guérin-Charbonnel C, Lasla H, Gouraud W, Canon JL, Gombos A, Dalenc F, Delaloge S, Lemonnier J, Loussouarn D, Verrièle V, Campone M. Jézéquel P, et al. Among authors: kerdraon o. Breast Cancer Res. 2019 May 17;21(1):65. doi: 10.1186/s13058-019-1148-6. Breast Cancer Res. 2019. PMID: 31101122 Free PMC article.
[An intrusive ovarian tumour].
Sourty B, Kerdraon O, Verrièle V, Raro P, Valo I. Sourty B, et al. Among authors: kerdraon o. Ann Pathol. 2022 Jul;42(4):345-349. doi: 10.1016/j.annpat.2022.02.006. Epub 2022 May 18. Ann Pathol. 2022. PMID: 35595595 French. No abstract available.
60 results